Raising Cane's and IPSY Team Up to Launch "Moisturizing Sauce," The Latest Skincare Craze for Craveably Glowing Skin
The Chicken Finger sensation and world's largest beauty subscription are redefining the future of skincare with a moisturizer so delectable it'll have users looking - and feeling - like a true snack
Bitcoin price flips volatile as traders eye $84.5K breakout
Bitcoin ( BTC ) repeated earlier volatility at the April 1 Wall Street open as US trade tariff talk kept markets nervous.BTC/USD 1-hour chart. Source: Cointelegraph/TradingViewBitcoin stays erratic ahead of crunch tariffsData from Cointelegraph Markets Pro and TradingView showed BTC/USD making ...
CentralReach Named to Inc. Magazine's 2025 List of Fastest-Growing Private Companies in the Southeast for 5th Time
Fort Lauderdale, FL, April 01, 2025 ( GLOBE NEWSWIRE ) -- CentralReach, a leading provider of Autism and IDD Care software for ABA, multidisciplinary, and special education, today was named to the Inc.
Transgene Appoints Chief Technical Officer ( CTO ) to Power Future Innovations
Strasbourg, France, April 1, 2025, 5:45 p.m. CET - Transgene TNG, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased to announce the appointment of Simone Steiner, PhD, as Chief Technical Officer ( CTO ) , effective immediately.
ARGAN: RENTAL INCOME UP +10% IN Q1 2025
Quarterly financial information - Neuilly-sur-Seine, Tuesday, April 1, 2025 - 5.45 pm ...
Valneva's Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
With this extension, IXCHIQ®, the first vaccine against the chikungunya virus ( CHIKV ) , is now available for administration for individuals 12 years of age and older in the European Union ( EU ) .
Transgene Appoints Chief Technical Officer ( CTO ) to Power Future Innovations
Dr. Simone Steiner will focus on improving the manufacturing processes of individualized immunotherapies based on myvac® platform Strasbourg, France, April 1, 2025, 5:45 p.m.
Valneva's Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
With this extension, IXCHIQ®, the first vaccine against the chikungunya virus ( CHIKV ) , is now available for administration for individuals 12 years of age and older in the European Union ( EU ) .
COFACE SA: Disclosure of total number of voting rights and number of shares in the capital as at March 31, 2025
COFACE SA: Disclosure of total number of voting rights and number of shares in the capital as at March ...
